Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adham S Bear

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2012
Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?Adham S Bear, Richard A Morgan, Kenneth Cornetta, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Scientific Reports|April 15, 2025
LOXHD1 is an oncofusion-regulated antigen of ewing sarcomaTatiana Blanchard, Pouya Faridi, Chong Xu, et al.
Nature Communications|July 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targetingAdham S Bear, Tatiana Blanchard, Joseph Cesare, et al.
The Journal of Clinical Investigation|September 17, 2024
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumorsAdham S Bear, Rebecca B Nadler, Mark H O'Hara, et al.
Cancer Cell|December 13, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safetyAnže Smole, Alexander Benton, Mathilde A Poussin, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2012
Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?Adham S Bear, Richard A Morgan, Kenneth Cornetta, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Scientific Reports|April 15, 2025
LOXHD1 is an oncofusion-regulated antigen of ewing sarcomaTatiana Blanchard, Pouya Faridi, Chong Xu, et al.
Nature Communications|July 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targetingAdham S Bear, Tatiana Blanchard, Joseph Cesare, et al.
The Journal of Clinical Investigation|September 17, 2024
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumorsAdham S Bear, Rebecca B Nadler, Mark H O'Hara, et al.
Cancer Cell|December 13, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safetyAnže Smole, Alexander Benton, Mathilde A Poussin, et al.
Pageof 2